These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 32019187)

  • 1. NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy.
    Lim RR; Wieser ME; Ganga RR; Barathi VA; Lakshminarayanan R; Mohan RR; Hainsworth DP; Chaurasia SS
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.
    Ikeda T; Nakamura K; Kida T; Oku H
    Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):387-403. PubMed ID: 34379187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiles of NOD-like receptors and regulation of NLRP3 inflammasome activation in Toxoplasma gondii-infected human small intestinal epithelial cells.
    Chu JQ; Gao FF; Wu W; Li C; Pan Z; Sun J; Wang H; Huang C; Lee SH; Quan JH; Lee YH
    Parasit Vectors; 2021 Mar; 14(1):153. PubMed ID: 33712075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
    Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
    Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.
    Yang Y; Jiang G; Huang R; Liu Y; Chang X; Fu S
    Biochem Pharmacol; 2023 Jun; 212():115569. PubMed ID: 37100255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy.
    Zheng X; Wan J; Tan G
    Front Immunol; 2023; 14():1151185. PubMed ID: 37180116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets.
    Raman KS; Matsubara JA
    Ocul Immunol Inflamm; 2022 Feb; 30(2):470-478. PubMed ID: 33026924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Role of NOD-Like Receptors in Infectious and Immunological Diseases.
    Lupfer CR; Anand PK; Qi X; Zaki H
    Front Immunol; 2020; 11():923. PubMed ID: 32508824
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen receptors participate in carcinogenesis signaling pathways by directly regulating NOD-like receptors.
    Fan W; Gao X; Ding C; Lv Y; Shen T; Ma G; Yan L; Song S
    Biochem Biophys Res Commun; 2019 Apr; 511(2):468-475. PubMed ID: 30797557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of pattern recognition receptor signalling in the development of age related macular degeneration: the role of toll-like-receptors and the NLRP3-inflammasome.
    Brandli A; Vessey KA; Fletcher EL
    J Neuroinflammation; 2024 Mar; 21(1):64. PubMed ID: 38443987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy.
    Chen H; Zhang X; Liao N; Mi L; Peng Y; Liu B; Zhang S; Wen F
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):978-985. PubMed ID: 29450537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy.
    Kuo CY; Maran JJ; Jamieson EG; Rupenthal ID; Murphy R; Mugisho OO
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
    Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
    Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of TSPO-VDAC complex is correlated with NLRP3 inflammasome activation in diabetic retinopathy.
    Guo Y; Sun Z; Wang L; Jiang R; Shu Q; Xu G
    Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36205135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?
    van der Wijk AE; Hughes JM; Klaassen I; Van Noorden CJF; Schlingemann RO
    J Leukoc Biol; 2017 Oct; 102(4):993-1001. PubMed ID: 28724696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.
    Van Hove I; Hu TT; Beets K; Van Bergen T; Etienne I; Stitt AW; Vermassen E; Feyen JHM
    Prog Retin Eye Res; 2021 Nov; 85():100966. PubMed ID: 33775825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.
    Mugisho OO; Aryal J; Shome A; Lyon H; Acosta ML; Green CR; Rupenthal ID
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review.
    Suriyasekeran K; Santhanamahalingam S; Duraisamy M
    Adv Exp Med Biol; 2021; 1307():357-373. PubMed ID: 32166636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of neovascular glaucoma. Etiopathogenesis and treatment.
    Dumbrăveanu L; Cușnir V; Bobescu D
    Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study.
    Bamashmus MA; Gunaid AA; Khandekar RB
    Indian J Ophthalmol; 2009; 57(4):293-8. PubMed ID: 19574698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.